The testing kit is intended for non-invasive diagnosis of the sex of a child by detecting the sex gene (SRY) of the fetus in the blood plasma of a pregnant woman.
Detection of the SRY gene indicates a male fetus, if this gene was not detected, the fetus is female.
The kit is designed for quantitative detection of the human immunodeficiency virus (HIV-1) in order to diagnose the HIV infection, choose an antiretroviral therapy regimen, monitor the progression of the HIV infection and/or the effectiveness of the antiretroviral therapy, and is also recommended for dispensary registration.
The kit is designed for quantitative detection of the hepatitis B virus DNA in patients with suspected infection and determination of viral load in patients with the detected hepatitis B virus to choose an appropriate therapy and evaluate its effectiveness.
The kit is designed for qualitative and quantitative detection of hepatitis D virus RNA in patients with suspected infection and determination of viral load in patients with detected hepatitis D virus to choose the correct therapy and evaluate its effectiveness.
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus with differentiation of the B.1.1.529 variant (Omicron). The study is important for making a differentiated diagnosis and solving epidemiological problems.